TREM2 and myeloid sarcoma: Induction of DAM-associated molecules, including transcribed and soluble TREM2 (sTREM2), characterized secondary progressive MS (SPMS) and supported its differential diagnosis.<h4>Interpretation</h4>We thus identified MS stage-specific CSF signatures and shared cellular features of degeneration detectable in CSF of PMS patients.